Capecitabine is an oral chemotherapy drug used for colorectal and breast cancers. It converts into 5-fluorouracil in the body to inhibit cancer cell growth. It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics and Nucleosides. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Xeloda, Capiibine, Capecitibine and Captabin. Its PubChem CID is 60953.
Capecitabine
| CAS No | 154361-50-9 |
|---|---|
| Molecular Formula | C15H22FN3O6 |
| Molecular Weight | 359.35 g/mol |
| Synonyms | Pentyl [1-(3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Capecitabine is an oral chemotherapy drug used for colorectal and breast cancers. It converts into 5-fluorouracil in the body to inhibit cancer cell growth. It is grouped under the following drug class(es): Antineoplastic agents, Cytotoxics and Nucleosides.
The listed CAS number is 154361-50-9.
The listed molecular formula is C15H22FN3O6.
The listed molecular weight is 359.35 g/mol.
Pentyl [1-(3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]carbamate.
The source lists Xeloda, Capiibine, Capecitibine and Captabin.